Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Osteoporosis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
Osteoporosis, a condition identified by diminished bone density and structural bone quality, continues to impose a significant health burden worldwide. According to a recent epidemiology forecast, total prevalent cases in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) are projected to rise strikingly from 51,169,521 in 2023 to 58,050,255 by 2033. This anticipated increase underscores the necessity for healthcare systems to prioritize bone health and fracture prevention strategies.
Increasing Diagnosed Prevalence
Parallel to the incremental rise in total osteoporosis cases, diagnosed prevalent cases in the 7MM are expected to mount from 20,291,551 in 2023 to 22,570,292 by 2033. This increase calls for enhanced awareness and better diagnostic processes to ensure timely management and treatment of osteoporosis, thereby curbing the dire complications associated with bone fractures.
Age and Gender Dynamics
The report reflects comprehensive data segmented by age and sex, covering the total and diagnosed prevalent cases of both primary osteoporosis and secondary osteoporosis, as well as osteopenia. The data suggests that women, particularly postmenopausal, continue to bear a significant portion of the disease burden. Further, the report anticipates a notable increase in both types of osteoporosis among aging populations, consistent with broader demographic trends and increased life expectancy.
Strategic Implications for the Healthcare Sector
The implications of the forecast for healthcare providers, policymakers, and pharmaceutical companies are profound. With the ascertainment of age groups most at risk, stakeholders are afforded the ability to strategize effectively and prioritize resources. As the call for osteoporosis therapeutics intensifies with the growing patient population, these insights will be indispensable in informing product development, market positioning, and patient care pathways.
Conclusion
The projection of osteoporosis's burgeoning global prevalence by 2033 presents an urgent need for a concerted and systematic approach to address this escalating health concern. It is critical for the international healthcare community to not only emphasize prevention and early detection but also to ensure that those living with osteoporosis today have access to the necessary care and support to manage their condition effectively, improving quality of life and reducing the risk of fracture.
For more information about this report visit https://www.researchandmarkets.com/r/j3119z
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
